Sunset notice - after thousands of hits, dozens of direct conversations on Twitter, and lots of media (honestly, too much), I’m “officially” giving notice that I no longer intend to actively maintain this document. Views have trickled to dozens a day. I am no longer updating this document, but I’ll leave it up for posterity. To our good health - Luke, September 2022
💊 A Patient’s Guide to TPOXX Access
If you have monkeypox (“mpx”) and are trying to access tecovirimat (TPOXX), this guide is for you!
💬 This guide is also available in Brazilian Portuguese translated by volunteer @BenLyons55 - thank you Ben! If you’d like to translate this document into other languages, please DM me on Twitter @Luke_RB.
Scope
Note that this guide assumes that you know about mpx as a disease and that you live in the US. This guide does not talk about vaccines. To learn more about vaccines and getting one:
Intro
This document shouldn’t exist. Access to medication should be easy. While accessing TPOXX has become easier since the beginning of this outbreak, accessing TPOXX remains complicated. This document tries to make it less complicated.
Disclaimer
This is an entirely amateur effort that relies on volunteers to contribute information. None of the below constitutes medical advice. Please talk to a medical professional if you are feeling sick, or think you may have been exposed to mpx.
Request an update
Anyone can request an addition or update through DM (@Luke_RB on Twitter).
Document structure
This document is written in “plain English”[1] with footnote references (little numbers above the words). If you want to read the underlying detail that supports the “plain English”, jump to the footnotes. Detail is also sometimes provided via hyperlink.
TPOXX is a drug used to treat smallpox, and can also treat people who have mpx.[2]
TPOXX stops the mpx virus from making more copies of itself in the cells of your body.[3]
Some people report feeling better within 24 hours. Others report feeling better in a few days.[4] No large efficacy trials have been completed in humans to date. Prior to this outbreak, monkeypox has not regularly spread in large numbers beyond Africa, so there have not been opportunities to conduct research on efficiency of vaccines and clinical treatments like TPOXX (and it’s not ethical to intentionally infect people then try to treat them!). Efficacy has been evaluated in monkey and rabbit models. These animal models show TPOXX is beneficial in reducing the risk of death, lesion count, and viral load.
A recently published article in the The Lancet reports that “One patient [who] was treated with tecovirimat (600 mg twice daily for 2 weeks orally)... had a shorter duration of viral shedding and illness (10 days hospitalization) compared with the other six patients.”
This 2018 New England Journal of Medicine article is highly detailed and contains many deep links to underlying studies related to safety and efficacy: Oral Tecovirimat for the Treatment of Smallpox. I recommend putting on your lab coat on and skip to the Results section 🤓
Most people taking TPOXX take it as pills. Some people with serious mpx cases may get TPOXX as an IV drip. When you take TPOXX pills, you should eat a meal with lots of fat about a half hour before taking the pills (25g fat / 600 calories).
Some people may get headaches or upset stomachs. You should always tell your doctor about all drugs you are taking, especially if you are diabetic or take any medications that make you sleepy: TPOXX has known interactions with some drugs that could be dangerous. People with an HIV diagnosis should also discuss interactions with their antiretrovirals (ART) including:
Until very recently, TPOXX has only been tested in humans for safety. Healthy, uninfected people were given doses and they were monitored for adverse reactions. A recently published article in the The Lancet reports that “One patient [infected with Monkeypox who] was treated with tecovirimat (600 mg twice daily for 2 weeks orally) experienced no adverse effects.”
The CDC updated the rules about getting TPOXX meds on Jul 22, 2022. Here are some important facts:
Most of this info is from this page from CDC, the Centers for Disease Control and Prevention. This is the page they put up for doctors. However, mpx is very new for many doctors, and they may not know all the steps here. This is helpful for you to know, too. The most interesting document on this page is the Protocol 6402 PDF, which is the source of many of the footnotes above.
Being familiar with your local health department’s messaging to doctors on TPOXX will be helpful to you. Usually, getting TPOXX meds depends on your local health department. For example, doctors in New York City must go through the NYC Department of Health (“NYC DOH''). Google for your local health department, and try to find any websites that give instructions to doctors. Here’s the one for NYC DOH, for example.
I recommend trying to find a doctor in the following order. You can also try reaching out to multiple doctors at once.
Depending on the severity of your cases, recovery could take several weeks. You will likely experience isolation. You may need to take time off from work, which can be financially challenging and additionally stressful. Combined with the pain, fighting for your own healthcare, and the stigma around this, the whole experience can be mentally, emotionally, and socially exhausting.
The community is going through this together - find others who are going through it and be there for each other. Reach out to friends virtually. Lean on those in your support network that you trust.
I was very lucky to have people who went through this before me and a humblingly boundless social network guide me through it (thank you Peter, Joey, Mark, Kyle, John, my parents, my PCP - endless friends and strangers on Twitter and Instagram). They gave me emotional support, practical advice on dealing with the pain, logistical advice on accessing TPOXX, etc. After you have recovered, consider doing the same. This might look like:
The early parts of this document are intended to be broadly applicable to accessing TPOXX anywhere in the United States. The sections below provide specific advice for accessing TPOXX in particular cities, including a directory of providers we know are prescribing TPOXX. I had hoped that the Jul 22, 2022 update from CDC would significantly simplify access to TPOXX across the country. As of writing (early August), that has turned out to only be partially true. To respond, I’ve started adding back some city-specific guidance on how to acquire TPOXX. These sections are populated by people with first-hand knowledge of accessing TPOXX based on the as-of date of the below information.
Last updated Aug 4, 2022
You should start with the instructions above and your primary care prescriber. If you are having a hard time getting TPOXX using this route, consider the prescribers below who we know prescribe TPOXX. Please message @luke_rb on Twitter if any of the below is inaccurate:
Potentially avoid CityMD - as of Aug 4, 2022, getting reports that they are requiring a positive test result to proceed.
* These prescribers have requested to be on this list. The remaining prescribers are known to provide this medication based on second-hand feedback from others.
* * Got good feedback from getting it here on Aug 4, 2022
One report from Philly patient in late August: Mazzoni Center (215-563-0658)
Los Angeles
One report from Los Angeles of having acquired TPOXX using this method:
Report from a Boston patient in late July:
Hey! Thanks for posting the TPOXX info online! Just wanted to share my experience for the Google Doc. In Boston, I got TPOXX at the Massachusetts General Hospital (MGH) through the Sexual Health Clinic before I got my positive test results back thanks to some help from my PCP. The sexual health clinic number is 617-726-2748 and you don't need insurance to get services from MGH
Second report from a Boston patient in late August:
Family Center for Infectious Diseases (FCID)
1801 W Taylor #3 (MC 731)
Chicago, IL 60612
P: 312-996-8337
Had contact from an infectious diseases doctor who let me know they are prescribing TPOXX here: 312-926-8358
San Francisco
Here is a note from a prescriber to a patient in Austin.
“My understanding of the current process is that we provide clinical history and a request for TPOXX use to the Austin DPH. The medication use and dispensing is approved by Austin DPH. We [the prescriber] do not write the prescription. The medication comes from the supply that Austin DPH has and is delivered to us. I believe the process overall is in flux as information and recommendations change, coordinating between states and CDC. We will have more paperwork to do along the way as well as follow ups at certain periods of time, which is part of the TPOXX emergency use authorization protocol. I will work on deciphering those details and will let you know.”
Last updated Aug 4, 2022
Information above provided by a doctor in Atlanta. If the primary care doctor practices at Emory or Grady needs support prescribing TPOXX they can page Infectious disease for assistance.
Known to be providing vaccines and TPOXX: UW Medicine Sexual Health Clinic at Harborview - (206) 744-3590
Multnomah County STD Clinic - 619 NW 6th Ave, Portland, OR 97209 - 503-988-3700
Follow the three steps above. These steps apply to almost every city, generally speaking. If you are able to obtain TPOXX in your city, please contribute that city specific information by DM’ing me on Twitter.
Assorted musings and notes from when I was really going through it.
The answer here is complicated, but this letter does a good job of explaining the technical regulatory reasons why access is complicated and what can be done to change them. Suggested listenings and readings on this question:
[1] I only speak English. If you are interested in creating a version of this document in other languages, please be my guest! Copy / paste and let me know where the link is so we can cross-link to each other’s documents.
[2] TPOXX (drug name: tecovirimat) is an antiviral medication approved for the treatment of smallpox which is currently being used “off-label” to treat monkeypox.
[3] TPOXX interrupts a protein synthesis process that the virus needs to infect the next cell. TPOXX (tecovirimat) targets and inhibits the activity of the orthopoxvirus VP37 protein (encoded by and highly conserved in all members of the orthopoxvirus genus) and blocks its interaction with cellular Rab9 GTPase and TIP47, which prevents the formation of egress-competent enveloped virions necessary for cell-to-cell and long-range dissemination of virus. I also recommend Mark’s write-up, here: TPOXX FAQ for NYC
[5] CDC Protocol 6402 section 2.1.1 Primary or early empiric treatment
Tecovirimat treatment may be initiated for patients with laboratory confirmed non-variola orthopoxvirus infection or suspected infection based on known exposure(s) and/or clinical manifestations of disease. Patients with an initial negative OPXV test, but for whom both epidemiologic and clinical evidence suggests OPXV disease (particularly if clinical progression is worsening), should be re-tested but be treated with tecovirimat while results are pending. If results from re-testing confirm orthopoxvirus, patients should continue tecovirimat treatment. If results from re-testing are in agreement with the initial negative orthopoxvirus results, tecovirimat should be suspended in those patients.
[6] CDC Protocol 6402 section 7.0 CLINICAL ASSESSMENT AND MONITORING OF PATIENTS
Clinical assessment and monitoring can be conducted in person or by telemedicine, whichever is feasible.
[7] FACT SHEET: U.S. Department of Health and Human Services Response to the Monkeypox Outbreak: “Making treatment courses available for free: Prior to the start of the outbreak, the SNS held more than 1.7 million courses of TPOXX, or tecovirimat, in its immediate holdings. These treatments have and continue to be made available to states and territories for free.”
[8] CDC Protocol 6402 section 2.1.3 Post-exposure prophylaxis (PEP)
Tecovirimat may be considered for post-exposure prophylaxis on an individual case-by-case basis in consultation with CDC (Emergency Operations Center [EOC] (770) 488-7100; poxvirus@cdc.gov) depending on the known high-risk exposure to a confirmed or probable case of NV-OPXV infection (as defined on https://www.cdc.gov/poxvirus) and clinical conditions that necessitate an alternative or complementary option to PEP vaccination based on clinical judgment, including taking into account exposure risk level and clinical status of the exposed individual (e.g., allergic to vaccine components, immunocompromising conditions).